H. A. Holt

1.5k total citations
54 papers, 1.2k citations indexed

About

H. A. Holt is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, H. A. Holt has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pharmacology, 30 papers in Molecular Medicine and 14 papers in Infectious Diseases. Recurrent topics in H. A. Holt's work include Antibiotics Pharmacokinetics and Efficacy (39 papers), Antibiotic Resistance in Bacteria (30 papers) and Pneumonia and Respiratory Infections (11 papers). H. A. Holt is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (39 papers), Antibiotic Resistance in Bacteria (30 papers) and Pneumonia and Respiratory Infections (11 papers). H. A. Holt collaborates with scholars based in United Kingdom, Switzerland and Zimbabwe. H. A. Holt's co-authors include M. J. Bywater, D. S. Reeves, Alasdair MacGowan, D. S. Reeves, Karen E. Bowker, Mandy Wootton, L. O. White, Chris Rogers, J. M. Broughall and A. M. Lovering and has published in prestigious journals such as The Lancet, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

H. A. Holt

54 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. A. Holt United Kingdom	21	720	568	397	229	180	54	1.2k
W. A. Craig United States	14	576 0.8×	395 0.7×	273 0.7×	213 0.9×	180 1.0×	17	894
K. Dornbusch Sweden	16	306 0.4×	593 1.0×	305 0.8×	214 0.9×	200 1.1×	47	1.1k
Marie-Dominique Kitzis France	19	683 0.9×	799 1.4×	523 1.3×	411 1.8×	198 1.1×	48	1.5k
C H Nightingale United States	17	657 0.9×	325 0.6×	427 1.1×	192 0.8×	115 0.6×	37	1.0k
Alexander A. Firsov Russia	21	992 1.4×	851 1.5×	357 0.9×	468 2.0×	255 1.4×	73	1.4k
Meridith E. Erwin United States	15	370 0.5×	398 0.7×	293 0.7×	376 1.6×	293 1.6×	44	887
N. Brenwald United Kingdom	18	704 1.0×	709 1.2×	786 2.0×	411 1.8×	124 0.7×	27	1.5k
Sofia K. Kasiakou Greece	14	645 0.9×	888 1.6×	560 1.4×	136 0.6×	98 0.5×	16	1.4k
J. Prieto Spain	18	397 0.6×	300 0.5×	483 1.2×	318 1.4×	122 0.7×	79	1.0k
M L van Ogtrop Netherlands	14	381 0.5×	335 0.6×	274 0.7×	341 1.5×	162 0.9×	20	981

Countries citing papers authored by H. A. Holt

Since Specialization

Citations

This map shows the geographic impact of H. A. Holt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. A. Holt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. A. Holt more than expected).

Fields of papers citing papers by H. A. Holt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. A. Holt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. A. Holt. The network helps show where H. A. Holt may publish in the future.

Co-authorship network of co-authors of H. A. Holt

This figure shows the co-authorship network connecting the top 25 collaborators of H. A. Holt. A scholar is included among the top collaborators of H. A. Holt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. A. Holt. H. A. Holt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

MacGowan, Alasdair, Karen E. Bowker, Mandy Wootton, & H. A. Holt. (1999). Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and streptococci of Lancefield Groups A and G. Journal of Antimicrobial Chemotherapy. 44(6). 761–766. 18 indexed citations

MacGowan, Alasdair, Caroline Rynn, Mandy Wootton, et al.. (1999). In vitro assessment of colistin's antipseudomonal antimicrobial interactions with other antibiotics. Clinical Microbiology and Infection. 5(1). 32–36. 41 indexed citations

Bowker, Karen E., Mandy Wootton, Chris Rogers, et al.. (1999). Comparison of in-vitro pharmacodynamics of once and twice daily ciprofloxacin. Journal of Antimicrobial Chemotherapy. 44(5). 661–667. 23 indexed citations

MacGowan, Alasdair, Karen E. Bowker, Mandy Wootton, & H. A. Holt. (1999). The in vitro activity of moxifloxacin against Haemophilus influenzae and Moraxella catarrhalis explored using a pharmacodynamic model. Clinical Microbiology and Infection. 5(4). 195–200. 5 indexed citations

Bowker, Karen E., H. A. Holt, Roger Lewis, D. S. Reeves, & Alasdair MacGowan. (1998). Comparative pharmacodynamics of meropenem using an in-vitro model to simulate once, twice and three times daily dosing in humans. Journal of Antimicrobial Chemotherapy. 42(4). 461–467. 18 indexed citations

MacGowan, Alasdair, Karen E. Bowker, H. A. Holt, Mandy Wootton, & D. S. Reeves. (1997). Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria. Journal of Antimicrobial Chemotherapy. 40(4). 503–509. 42 indexed citations

Bowker, Karen E., H. A. Holt, David S. Reeves, & Alasdair MacGowan. (1996). Bactericidal activity, post antibiotic effect and modified controlled effective regrowth time of meropenem at high concentrations. Journal of Antimicrobial Chemotherapy. 38(6). 1055–1060. 19 indexed citations

Bowker, Karen E., Mandy Wootton, H. A. Holt, D. S. Reeves, & Alasdair MacGowan. (1996). The in-vitro activity of trovafloxacin and nine other antimicrobials against 413 anaerobic bacteria. Journal of Antimicrobial Chemotherapy. 38(2). 271–281. 12 indexed citations

MacGowan, Alasdair, Mandy Wootton, Alan J. Hedges, et al.. (1996). A new time-kill method of assessing the relative efficacy of antimicrobial agents alone and in combination developed using a representative β-lactam, aminoglycoside and fluoroquinolone. Journal of Antimicrobial Chemotherapy. 38(2). 193–203. 30 indexed citations

10.

Wootton, Mandy, Alan J. Hedges, Karen E. Bowker, et al.. (1995). A critical assessment of the agar dilution chequerboard technique for studying in-vitro antimicrobial interactions using a representative β-lactam, aminoglycoside and fluoroquinolone. Journal of Antimicrobial Chemotherapy. 35(5). 569–576. 8 indexed citations

11.

White, L. O., et al.. (1994). Assay of serum teicoplanin concentrations in clinical specimens: a comparison of isocratic high performance liquid chromatography with polarisation fluoroimmunoassay and bioassay. Journal of Antimicrobial Chemotherapy. 34(3). 425–429. 4 indexed citations

12.

Reeves, D. S., H. A. Holt, M. J. Bywater, & Alasdair MacGowan. (1993). The activity of piperacillin/tazobactam against clinical isolates collected in 20 UK centres and the design of a disc test for susceptibility testing. Journal of Antimicrobial Chemotherapy. 32(1). 51–61. 7 indexed citations

13.

Reeves, D. S., M. J. Bywater, & H. A. Holt. (1993). The activity of cefpirome and ten other antibacterial agents against 2858 clinical isolates collected from 20 centres. Journal of Antimicrobial Chemotherapy. 31(3). 345–362. 26 indexed citations

14.

Reeves, D. S., H. A. Holt, Ian Phillips, et al.. (1991). Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres. Journal of Antimicrobial Chemotherapy. 27(4). 469–474. 19 indexed citations

15.

Holt, H. A., M. J. Bywater, & D. S. Reeves. (1990). In-vitro activity of cefpodoxime against 1834 isolates from domiciliary infections at 20 UK centres. Journal of Antimicrobial Chemotherapy. 26(suppl E). 7–12. 15 indexed citations

16.

MacGowan, Alasdair, H. A. Holt, & D. S. Reeves. (1990). In-vitro synergy testing of nine antimicrobial combinations against Listeria monocytogenes. Journal of Antimicrobial Chemotherapy. 25(4). 561–566. 16 indexed citations

17.

MacGowan, Alasdair, H. A. Holt, M. J. Bywater, & D. S. Reeves. (1990). In vitro antimicrobial susceptibility ofListeria monocytogenes isolated in the UK and otherListeria species. European Journal of Clinical Microbiology & Infectious Diseases. 9(10). 767–770. 28 indexed citations

18.

Lovering, A. M., et al.. (1988). Resistance of bacterial pathogens to four aminoglycosides and six other antibacterials and prevalence of aminoglycoside modifying enzymes, in 20 UK centres. Journal of Antimicrobial Chemotherapy. 22(6). 823–839. 17 indexed citations

19.

White, L. O., Richard Edwards, H. A. Holt, et al.. (1988). The in-vitro degradation at 37°C of vancomycin in serum, CAPD fluid and phosphate-buffered saline. Journal of Antimicrobial Chemotherapy. 22(5). 739–745. 35 indexed citations

20.

Reeves, D. S., M. J. Bywater, & H. A. Holt. (1987). Activity in vitro of CGP 31608, a new penem antibacterial agent. Journal of Antimicrobial Chemotherapy. 20(2). 165–178. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact